Sharon Kochan, Executive VP U.S. Generics at PERRIGO CO (PRGO), sold 11,567 shares at $35.41 ($410K) on 2008-08-20, disclosed to the SEC on 2008-08-22.
Open-market sale of $410k PRGO by Executive VP U.S. Generics. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.41 | 2,578 | $91K | 22.3% |
| 2 | $35.42 | 2,532 | $90K | 21.9% |
| 3 | $35.42 | 1,567 | $56K | 13.5% |
| 4 | $35.43 | 1,422 | $50K | 12.3% |
| 5 | $35.44 | 200 | $7K | 1.7% |
| 6 | $35.45 | 100 |
| $4K |
| 0.9% |
| 7 | $35.46 | 1,068 | $38K | 9.2% |
| 8 | $35.47 | 500 | $18K | 4.3% |
| 9 | $35.49 | 1,100 | $39K | 9.5% |
| 10 | $35.50 | 500 | $18K | 4.3% |
| Total | $35.44 avg | 11,567 | $410K | 100% |
| Filing → |
| PRGO | SELL | 2016-03-04 | $373K | — | Filing → |
| PRGO | SELL | 2014-11-12 | $839K | — | Filing → |
| PRGO | SELL | 2013-11-19 | $69K | — | Filing → |